Surgepays Stock Analysis

Surgepays Stock Analysis Notes

About 32.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.17. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surgepays has Price/Earnings To Growth (PEG) ratio of 0.53. The entity recorded a loss per share of 1.18. The firm had not issued any dividends in recent years. Surgepays had 1:50 split on the 2nd of November 2021. SurgePays, Inc., a financial technology and telecommunications company, provides services to the underbanked community in the United States. Further, it operates a bilingual operations center offering the Company with sales support, customer service, IT infrastructure design, graphic media, database programming, software development, revenue assurance, lead generation, and other various operational support services. Surgepays operates under SoftwareApplication classification in the United States and is traded on NASDAQ Exchange. It employs 32 people. To find out more about Surgepays contact Kevin Cox at 901 302 9587 or learn more at https://surgepays.com.

Surgepays Investment Alerts

Surgepays Upcoming and Recent Events

Surgepays Largest EPS Surprises

View All Earnings Estimates

Surgepays Stock Institutional Investors

Note, although Surgepays' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Surgepays Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 38.71 M.

Surgepays Profitablity

The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.72) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.72.

Management Efficiency

Surgepays has return on total asset (ROA) of (0.0151) % which means that it has lost $0.0151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0519) %, meaning that it created substantial loss on money invested by shareholders. Surgepays' management efficiency ratios could be used to measure how well Surgepays manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Surgepays' Return On Assets are most likely to increase significantly in the upcoming years. At this time, Surgepays' Non Current Assets Total are most likely to increase significantly in the upcoming years. The Surgepays' current Non Currrent Assets Other is estimated to increase to about 213.5 K, while Intangible Assets are projected to decrease to roughly 2 M.

Technical Drivers

As of the 28th of November, Surgepays has the Semi Deviation of 5.28, coefficient of variation of 2421.59, and Risk Adjusted Performance of 0.0404. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Surgepays, as well as the relationship between them. Please validate Surgepays information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Surgepays is priced more or less accurately, providing market reflects its prevalent price of 1.92 per share. Please also confirm Surgepays total risk alpha, which is currently at (0.69) to double-check the company can sustain itself at a future point.

Surgepays Price Movement Analysis

Surgepays Insider Trading Activities

Surgepays Outstanding Bonds

Surgepays Predictive Daily Indicators

Surgepays Forecast Models

Surgepays' time-series forecasting models are one of many Surgepays' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Surgepays' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Surgepays prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Surgepays shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Surgepays. By using and applying Surgepays Stock analysis, traders can create a robust methodology for identifying Surgepays entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Surgepays analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Surgepays analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Surgepays stock analysis indicators help investors evaluate how Surgepays stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Surgepays shares will generate the highest return on investment. By understating and applying Surgepays stock analysis, traders can identify Surgepays position entry and exit signals to maximize returns.

When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.